Blackstone buys life sciences investment firm Clarus
Blackstone has acquired Clarus, a life sciences investment firm. No financial terms were disclosed. The business will operate as Blackstone Life Sciences.
30 November 2018•2 mins read
Blackstone has acquired Clarus, a life sciences investment firm. No financial terms were disclosed. The business will operate as Blackstone Life Sciences.
Branford Castle acquires plant-nutrition firm Floratine as Fund III debut
13 November 2026 · 2 mins read
Carlyle agrees sale of Disguise to Yamaha after more than tripling revenue
13 November 2026 · 2 mins read
PE backs hematology care and diagnostics: 5 deals
13 November 2026 · 2 mins read
Arcline agrees Akron Bio sale to MaxCyte in $152m deal
12 November 2026 · 2 mins read
Nordic Capital-backed Inovalon agrees deal to buy prescription tech firm DrFirst
12 November 2026 · 2 mins read
Trinity Hunt’s Allvia adds Humani HR in first Canadian expansion
12 November 2026 · 1 min read
Aquiline backs Beni Solutions, provider of affordable small-business health plans
12 November 2026 · 1 min read
